PAARX
Price
$15.75
Change
+$0.04 (+0.25%)
Updated
Mar 7 closing price
Net Assets
2.11B
RLBCX
Price
$34.43
Change
+$0.18 (+0.53%)
Updated
Mar 7 closing price
Net Assets
237.28B
Ad is loading...

PAARX vs RLBCX

Header iconPAARX vs RLBCX Comparison
Open Charts PAARX vs RLBCXBanner chart's image
Putnam Dynamic Asset Allocation Bal R
Price$15.75
Change+$0.04 (+0.25%)
VolumeN/A
Net Assets2.11B
American Funds American Balanced R3
Price$34.43
Change+$0.18 (+0.53%)
VolumeN/A
Net Assets237.28B
PAARX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PAARX vs. RLBCX commentary
Mar 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAARX is a Buy and RLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 237B vs. PAARX (2.11B). PAARX pays higher dividends than RLBCX: PAARX (1.96) vs RLBCX (1.65). PAARX was incepted earlier than RLBCX: PAARX (22 years) vs RLBCX (23 years). PAARX (1.18) is less costly to investors than RLBCX (0.89). PAARX is a more actively managed with annual turnover of: 222.00 vs. RLBCX (171.00). PAARX has a lower initial minimum investment than RLBCX: PAARX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 4.82 vs. PAARX (0.64). RLBCX return over 5 years is better than : 32.76 vs. PAARX (17.04).
PAARXRLBCXPAARX / RLBCX
Total Expense Ratio1.180.89133%
Annual Report Gross Expense Ratio1.180.89133%
Fund Existence22 years23 years-
Gain YTD0.5110.93854%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.11B237B1%
Annual Yield % from dividends1.961.65119%
Returns for 1 year0.644.8213%
Returns for 3 years9.3316.5256%
Returns for 5 years17.0432.7652%
Returns for 10 years22.1250.7444%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APTO3.170.22
+7.46%
Aptose Biosciences. Inc.
CRL175.926.65
+3.93%
Charles River Laboratories International
CFB15.99N/A
N/A
CrossFirst Bankshares
XENE36.50-0.78
-2.09%
Xenon Pharmaceuticals
ALEC1.44-0.14
-8.86%
Alector